Dr. Chen became an Advisor to NewCap Partners in 2008.  A technical expert in the fields of life sciences, medical devices, diagnostics, environmental science, nanotechnology, and material science, he specializes in helping clients in those industries identify China-based institutes and companies for M&A, strategic alliances, and corporate equity investments. During the last few years, his efforts have focused on the formation of alliances between groups in China and the U.S. 
 
Frank has almost 20 years of experience in research and technology development at world-leading research institutes such as Los Alamos National Laboratory, NYU-Mount Sinai Hospital, Lawrence Livermore National Laboratory (Guest Scientist), and Lawrence Berkeley National Laboratory. His research has been funded by NIH, DOD, DARPA, NASA and private foundations.  He has gained business management and consulting experience working with startups, small, mid-cap, and Fortune 100 companies.
 
Dr. Chen served as the QB3 China Representative in 2007.  He is an Adjunct Professor of Nanotechnology at Zhejiang-California Nanosystems Institute, Zhejiang University, an Adjunct Professor of Chemistry and an Adjunct Professor of Biology both at Fudan University.
 
Frank has a Ph.D. in Biomedical Sciences from the Graduate Program of Los Alamos National Laboratory, and a B.S. in Biochemistry from Fudan University.  He is fluent in Mandarin, Shanghainese, and English.